(Q44546032)

4 December 2017

Warfarin dose adjustments based on CYP2C9 genetic polymorphisms (English)

1 reference

4 December 2017

1 reference

Mark W Linder

1

1 reference

4 December 2017

Stephen Looney

2

1 reference

4 December 2017

Jesse E Adams

3

1 reference

4 December 2017

Nancy Johnson

4

1 reference

4 December 2017

Deborah Antonino-Green

5

1 reference

4 December 2017

Nichole Lacefield

6

1 reference

4 December 2017

Bonny L Bukaveckas

7

1 reference

4 December 2017

Roland Valdes

8

1 reference

4 December 2017

1 December 2002

1 reference

Journal of Thrombosis and Thrombolysis

4 December 2017

1 reference

4 December 2017

14

1 reference

4 December 2017

3

1 reference

4 December 2017

227-232

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1025052827305

4 December 2017

0 references

cites work

A genetic algorithm to improve a neural network to predict a patient's response to warfarin.

1 reference

12 December 2020

High clearance of (S)-warfarin in a warfarin-resistant subject

1 reference

12 December 2020

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

1 reference

12 December 2020

Note on an exact treatment of contingency, goodness of fit and other problems of significance

1 reference

12 December 2020

Factors affecting the maintenance dose of warfarin

1 reference

12 December 2020

Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9

1 reference

12 December 2020

The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism

1 reference

12 December 2020

Genetic modulation of oral anticoagulation with warfarin

1 reference

12 December 2020

Chiral phase analysis of warfarin enantiomers in patient plasma in relation to CYP2C9 genotype.

1 reference

12 December 2020

Interindividual variability in sensitivity to warfarin--Nature or nurture?

1 reference

12 December 2020

Standardised initial warfarin treatment: evaluation of initial treatment response and maintenance dose prediction by randomised trial, and risk factors for an excessive warfarin response

1 reference

12 December 2020

Genetic association between sensitivity to warfarin and expression of CYP2C9*3

1 reference

12 December 2020

A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial

1 reference

12 December 2020

Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy.

1 reference

12 December 2020

Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment.

1 reference

12 December 2020

Allelic variants of human cytochrome P450 2C9: baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms.

1 reference

12 December 2020

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

12 December 2020

Cytochrome P450 polymorphisms are associated with reduced warfarin dose

1 reference

12 December 2020

Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans

1 reference

12 December 2020

Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions

1 reference

12 December 2020

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance.

1 reference

12 December 2020

Genetic analysis of CYP2C9 polymorphism in a Japanese population

1 reference

12 December 2020

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1025052827305

1 reference

Dimensions Publication ID

4 December 2017

0 references

1 reference